Evidence map›Paper›PMID 19225057›Full record

Trial reportChest2009

A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease.

Virginia Reichert, Xiangying Xue, Diane Bartscherer, Daniel Jacobsen, Christine Fardellone, Patricia Folan, Nina Kohn, Arunabh Talwar, Christine N Metz

Abstract readClinical Trial
In one paragraph

Trial report in Chest, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014
    Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PATH Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Virginia ReichertCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Xiangying XueThe Feinstein Institute for Medical Research, The North Shore-LIJ Health System, Manhasset, NY.
Diane BartschererCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Daniel JacobsenCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Christine FardelloneCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Patricia FolanCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Nina KohnThe Biostatistics Unit, The North Shore-LIJ Health System, Manhasset, NY.
Arunabh TalwarCenter for Tobacco Control, The North Shore-LIJ Health System, Manhasset, NY.
Christine N MetzThe Feinstein Institute for Medical Research, The North Shore-LIJ Health System, Manhasset, NY. Electronic address: cmetz@nshs.edu.

Funding

Cholinergic regulation of endothelial cell activationR01GM070727 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI METZ, CHRISTINE NOEL · 2006 to 2010
$1.2M
NIGMS NIH HHS R01 GM070727NIGMS NIH HHS R01GM070727
6 · The paper itself

Abstract

backgroundThe links among smoking, inflammation, and cardiovascular disease (CVD) are well established. Several studies have demonstrated that quitting smoking reverses the risk of coronary heart disease within 5 to 10 years. However, the immediate effects of quitting smoking on inflammatory biomarkers associated with CVD risk have not been well described.

methodsIn this pilot study, we examined a panel of circulating inflammatory biomarkers associated with CVD in "at-risk" women during the smoking cessation program. Forty-six women enrolled in a smoking cessation program consented to attend four study visits over 6 to 7 weeks. Health/medical information and blood were collected at each visit. Circulating levels of C-reactive protein (CRP), tumor necrosis factor (TNF), interleukin (IL)-6, soluble TNF receptor (sTNFR)-I, sTNFR-II, and soluble vascular cell adhesion molecule (sVCAM)-1 were measured, and changes between baseline levels (visit 1, while smoking) and visits 2 through 4 were determined.

resultsSignificant reductions in circulating levels of TNF, sTNFR-I, sTNFR-II, and sVCAM-1 were observed among participants over the course of the smoking cessation program. Serum levels of both IL-6 and CRP declined during the smoking cessation program; the changes were not statistically significant, however.

conclusionsThese findings suggest there are rapid consequences of smoking cessation on inflammatory biomarkers in women at risk for CVD. Additional, larger studies including diverse smokers desiring to quit are required to confirm changes in "measurable milestones" that could serve as motivating factors to assist smokers to quit.

Indexed as

Smoking CessationAdultAgedCardiovascular DiseasesCohort StudiesC-Reactive ProteinFemaleFollow-Up StudiesHumansInflammation MediatorsInterleukin-6Middle AgedPilot ProjectsReceptors, Tumor Necrosis FactorRisk FactorsVascular Cell Adhesion Molecule-1C-Reactive ProteinInflammation MediatorsInterleukin-6Receptors, Tumor Necrosis FactorVascular Cell Adhesion Molecule-1

Identifiers

PMID19225057
PMCPMC2707500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.